This application seek approval for rebaudioside M (a steviol glycoside) produced by the enzymatic conversion method, using enzymes derived from genetically modified Escherichia coli BL21.
The FSANZ 2024 Stakeholder Satisfaction Survey closes 15 November 2024 | Take the survey